by Vikas Shukla
(Gurgaon- Haryana)
QUESTION: I am 50 and have had type 2 diabetes for about 15 years. Despite diet and exercise, my fasting glucose is around 170 mg/dL and post-meal glucose is around 220 mg/dL while taking sitagliptin 100 mg and a glimepiride 2 mg/metformin 500 mg combination. My triglycerides are about 270 mg/dL, my blood pressure sometimes reaches 150/90, and I often have stomach problems. Which diabetes medicine would be suitable for me?
Your glucose is above the usual targets, so the treatment plan needs prompt review rather than an unmonitored dose increase or herbal remedy. No single medicine can be selected safely without your HbA1c, kidney function, urine albumin, heart history, eye and foot status, exact drug packages, and gastrointestinal symptoms. Current options may include adjusting metformin, replacing sitagliptin, adding an SGLT2 inhibitor or GLP-1-based medicine, or using insulin. The best choice depends on effectiveness, organ protection, low-glucose risk, side effects, availability, and cost.
Answer by Dr. Albana Greca, MD, MMedSc
Hi Vikas,
These readings indicate that the current regimen is not adequately controlling diabetes. For many adults, common individualized targets are 80–130 mg/dL before meals and below 180 mg/dL one to two hours after a meal begins.
Your combination tablet reportedly contains only 500 mg of metformin, but that does not mean you should increase it without review. Metformin dosing depends on kidney function, total daily intake, gastrointestinal tolerance, and other conditions.
Because you already have gastric symptoms, your clinician should determine whether metformin contributes to bloating, discomfort, or diarrhea. Taking it with food or using extended-release metformin may improve tolerance. Kidney function must be checked before any increase.
Sitagliptin 100 mg is the usual full daily dose when kidney function is adequate. A lower dose is required with reduced kidney function, so increasing it beyond 100 mg is not appropriate. Sitagliptin generally has modest glucose-lowering effectiveness.
Glimepiride can lower glucose effectively but may cause hypoglycemia and weight gain. Its dose should not be increased before reviewing kidney function, low-glucose episodes, and HbA1c.
Bring the actual Zunavia and Zoryl M-2 packages to the appointment so the doctor can confirm every active ingredient and avoid duplication. Our guide to diabetes medicine safety explains why this matters.
Your clinician may discuss an SGLT2 inhibitor, a GLP-1 receptor agonist, or another medicine based on your health profile. SGLT2 inhibitors can provide heart-failure and kidney protection in suitable patients. GLP-1-based treatments can lower HbA1c more strongly than sitagliptin and may support weight and cardiovascular goals.
A GLP-1-based medicine should not normally be combined with sitagliptin because the combination adds little benefit. These medicines also have different risks: SGLT2 inhibitors can contribute to genital infections, dehydration, and rare ketoacidosis, while GLP-1-based medicines commonly cause nausea or other digestive symptoms. Cost and availability also matter.
Not necessarily from these two readings alone, but insulin should not be viewed as a failure or as evidence that a doctor lacks knowledge. After 15 years, insulin production may have declined enough that insulin becomes the most effective option.
When there is no severe hyperglycemia or crisis, a GLP-1-based treatment is often considered before insulin if it is suitable and accessible. Insulin becomes especially important with symptoms, major weight loss, ketones, HbA1c above about 10%, glucose around 300 mg/dL or higher, acute illness, or failure of other treatment. Learn more in our insulin treatment guide.
Triglycerides around 270 mg/dL are elevated. Better glucose control, limiting alcohol and refined carbohydrates, and treating secondary causes may help. Because you are 50 and have diabetes, cardiovascular risk assessment and statin treatment should be discussed even when LDL appears “within limits.”
A single blood pressure of 150/90 does not establish persistent hypertension, but repeated values at this level require home monitoring and medical review. Blood pressure, cholesterol, smoking, kidney disease, and diabetes must be managed together to reduce heart attack and stroke risk.
Use a blood sugar log and review your HbA1c with the guidance on average glucose and treatment goals.
Do not replace prescribed medicine with an Ayurvedic product or add one without an ingredient-specific review. Evidence for diabetes benefit is weak, products may interact with medicines, and some preparations have contained toxic amounts of lead, mercury, or arsenic.
Arrange a diabetes appointment soon rather than waiting for the next routine eight-to-ten-month review. Seek same-day advice if glucose repeatedly reaches 300 mg/dL or higher, especially with thirst, frequent urination, dehydration, infection, or weight loss. Seek emergency care for vomiting, abdominal pain, difficult breathing, confusion, fainting, high ketones, glucose above 400 mg/dL, or a meter displaying “HI.”
Your current results justify treatment intensification, but prescribing a specific drug online would be unsafe. Ask for a full review of HbA1c, kidney function, cardiovascular risk, stomach symptoms, and medicine affordability. The next step could be a better-tolerated metformin plan, replacement of sitagliptin, addition of an organ-protective medicine, or insulin.
Educational safety note: This answer is for general diabetes education only. It does not replace personal medical advice, diagnosis, or treatment. Do not increase, stop, or replace sitagliptin, glimepiride, metformin, insulin, cholesterol or blood-pressure medicine, herbs, or supplements without speaking with your healthcare provider.
Last reviewed: July 2026.
Comments for Suitable Diabetic Medicine for me
|
||
|
||
|
||
|
Click here to add your own Comment / Follow up Ask the Doctor now? Simply click here to return to Type 2 diabetes information. |